FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
FITLIFE BRANDS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.23−0.16 (-1.91%)
Close on Oct 19, 2026
- Market cap
- $81.53M
- P/E (TTM)
- 43.3
- Dividend yield
- –
FITLIFE BRANDS, INC. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 12.3%
- Operating margin
- 3.8%
- Net margin
- 1.9%
- Return on equity, FY2025
- 5.1%
Financial strength
- Current ratio
- 1.46
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 5.2%
Valuation
- P/E ratio
- 43.3
- Price to sales
- 0.81
- Price to book
- 1.72
- Dividend yield
- –